Sachs European Life Sciences CEO Forum

Immunetune's development of a vaccine against SARS-CoV-2 has been published as part of a consortium in Nature Communications in July 2022. In this specific publication, named 'A third vaccination with a single T cell epitope confers protection in a murine model of...

Accelerating Cancer Immunotherapy Research (ACIR) has featured Immunetune's presentation during the Cancer Immunotherapy (CIMT) Annual Meeting 2022 held May 10-12 in Mainz, Germany. At CIMT, our CSO Jeroen van Bergen presented new preclinical results on our neoantigen...